Skip to main content
    N

    Nutriband Inc (NTRB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.81
    -0.29 (-4.75%)

    Market Cap: $74.15M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Nutriband Inc (NTRB) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Nutriband (NTRB) trades at 43.7x sales and 13.3x book value. Its P/S of 43.7x is above its 5-year median of 23.5x. Its forward P/E is 370.4x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E370.4x
    Price to sales43.7x
    Price to book13.3x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 64.2% above 8.1x.

    MultipleCurrent5-year median10-year median
    P/S43.7x23.5xN/A
    P/B13.3x4.5x8.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 99 months (10-year).

    Valuation History

    Over the 6 year ends shown, its P/S ranged from 9.6x in 2023 to 124.0x in 2020.

    Year endPriceP/SP/B
    2025$4.5422.2x7.3x
    2024$4.7123.3x4.7x
    2023$2.329.6x3.2x
    2022$3.6016.3x2.9x
    2021$10.0864.0x5.3x
    2020$15.00124.0x11.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NTRB

    What is NTRB's forward P/E ratio?

    Nutriband has a forward P/E ratio of 370.4x.

    Is NTRB stock overvalued?

    GNG's valuation label for NTRB is Overvalued.

    What is NTRB's price to sales ratio?

    Nutriband has a price to sales ratio of 43.7x.